Did you know that cheek lift procedures may be considered by individuals experiencing age-related midface volume loss or skin laxity? Aging can affect cheek volume, skin elasticity, and tissue position, which may alter facial contours. Surgical cheek lifts can address some of these structural changes, but not everyone wants to undergo an invasive procedure
Polynucleotide cheek treatments are minimally invasive options intended to improve selected midface skin-quality concerns. They may help address dryness, fine lines, and reduced elasticity but are not equivalent to a surgical lift or a conventional volumizing filler. Clinical evidence is promising but remains limited, and these treatments are less established for correcting substantial cheek volume loss.
This article will explore polynucleotide treatments for the cheeks, discussing their mechanism of action, skin treatment procedure, potential skin results, and associated risks.
Key Takeaways
- Polynucleotide treatments for the cheeks are minimally invasive options that may improve selected signs of skin aging, including dryness, fine lines, texture, and reduced elasticity.
- These treatments stimulate collagen and elastin production, improving skin elasticity, reducing fine lines, and enhancing hydration.
- Potential candidates include adults with selected skin-quality concerns and mild laxity who understand that PN is not a substitute for structural volume restoration or surgery.
- Improvements may develop gradually and may require repeat treatment, but the timing and duration vary according to the product, protocol, treatment area, and patient.
About: Medica Depot is your trusted all-in-one supplier, offering a range of high-quality medical injectables and supplies. Order Polynucleotides online at Medica Depot today! Whether for health professionals, plastic surgeons, dermatologists, licensed estheticians, or other specialists, we can offer genuine, brand-name products you may need. With Medica Depot, we prioritize serving you better to improve the patient’s quality of life.
Understanding Polynucleotide Treatments for Cheeks
Polynucleotides are long chains of nucleotide units, the building blocks of nucleic acids such as DNA and RNA. In aesthetic medicine, purified polynucleotide preparations are used in some injectable products intended to support skin hydration, texture, elasticity, and dermal remodeling. Their composition and regulatory status vary by product and market.
In aesthetic medicine, different polynucleotide products and formulations are being studied for skin rejuvenation. Early evidence suggests that some products may improve hydration, texture, elasticity, and fine lines. Collagen and elastin stimulation are proposed mechanisms, but outcomes depend on the formulation, treatment protocol, and patient.
When administered appropriately by qualified aesthetic professionals, patients can maximize the results of polynucleotide treatments. Aside from the quick procedure and minimal downtime, these are other advantages that patients can receive:
- Increased skin elasticity
- Possible reduction in the appearance of fine lines
- Improved skin texture and appearance
- Enhanced hydration
When to Consider Polynucleotide Treatments for Cheeks
Individuals considering polynucleotides for their cheeks often seek to improve skin quality and achieve a refreshed appearance. These treatments may address dryness, fine lines, and mild laxity, but they do not reliably restore substantial cheek volume or correct significant tissue descent. A consultation with a qualified provider is essential.
Adults with selected fine lines, dryness, or mild skin-quality changes who prefer a minimally invasive treatment may be considered for PN therapy. However, “natural composition” does not guarantee safety, and the treatment is not appropriate for everyone. Providers should assess allergies, active skin disease, bleeding risk, medications, pregnancy or breastfeeding, and realistic expectations.
When comparing polynucleotides and exosomes or conventional volumizing options, it is important to consider that these are different treatment categories. Polynucleotides are intended primarily to support skin quality and tissue remodeling, whereas volumizing fillers provide structural correction. Current evidence does not establish that PN produces longer-lasting results than conventional fillers, and “natural” does not automatically mean safer or more effective.
A study of intradermal long-chain polynucleotide injections reported age-group differences in measured skin outcomes, including pore appearance, skin thickness, tone, melanin-related measures, and wrinkles. Because the study evaluated a specific product and may have had a limited or noncomparative design, its findings should not be generalized to all PN products or interpreted as proof that PN safely rejuvenates the cheeks in every patient.
A study of intradermal long-chain polynucleotide injections reported age-group differences in measured skin outcomes, including pore appearance, skin thickness, tone, melanin-related measures, and wrinkles. Because the study evaluated a specific product and may have had a limited or noncomparative design, its findings should not be generalized to all PN products or interpreted as proof that PN safely rejuvenates the cheeks in every patient.
The Procedure and Recovery Process
Polynucleotide cheek treatments involve placing the product intradermally or at another product-specific depth using a needle or cannula. Only appropriately qualified medical professionals should perform this minimally invasive procedure in a suitable clinical setting. Providers must follow current product instructions, local regulations, infection-control standards, and appropriate training rather than relying on one universal technique.
Providers may mark the cheek area to plan injection sites and tailor the treatment to the patient’s anatomy. Dose, depth, and technique should follow product-specific instructions and clinical judgment. PN may improve skin quality, but it should not be expected to provide the same degree of cheek projection or volume restoration as a conventional filler.
During the procedure, patients may feel mild discomfort. Common short-term reactions include redness, swelling, tenderness, bruising, itching, and temporary injection-site papules or lumps. These effects often improve over several days, but the duration varies. Patients should follow provider-directed aftercare and should not take medication that affects bleeding without medical advice.
Patients should contact their medical provider if symptoms persist, worsen, or become unusually painful. Sudden severe pain, pale or dusky skin, rapidly increasing swelling, fever, or visual symptoms require urgent assessment. Following individualized aftercare instructions can support recovery, but no aftercare plan eliminates procedural risk.
Results and Long-Term Effects
The duration of polynucleotide treatment results for cheek procedures has not been firmly established across products and protocols. Improvements generally develop gradually as skin remodeling occurs and may require a series of treatments. Maintenance sessions may be considered, but the timing should be individualized rather than described as a fixed six- to twelve-month schedule.
Before-and-after photographs may illustrate individual treatment experiences, but they can be affected by lighting, facial expression, camera angle, concurrent procedures, and follow-up time. These polynucleotide cheek treatments may improve skin texture and elasticity in selected patients, but they do not guarantee a subtle midface lift or restoration of youthful contours.
Conclusion
Polynucleotide treatments are emerging minimally invasive options for improving selected cheek skin-quality concerns. They may support hydration, elasticity, texture, and the appearance of fine lines, but they do not provide the same structural volume or lifting effect as conventional fillers or surgery. Current evidence is promising but remains limited and product-specific.
As interest in minimally invasive aesthetic options grows, polynucleotides may be considered for carefully selected individuals with mild skin-quality changes. Patients should receive realistic information about the gradual nature of results, the limited long-term evidence, alternatives, and potential adverse effects before choosing treatment.
FAQs
1. What are polynucleotide treatments for cheeks?
Polynucleotide treatments for cheeks involve injecting solutions that stimulate collagen and elastin production. This provides a non-surgical option for skin rejuvenation and improves signs of aging.
2. Who are ideal candidates for polynucleotide cheek treatments?
Ideal candidates include adults with mild to moderate skin laxity and fine lines seeking a safe, minimally invasive alternative to traditional fillers for facial rejuvenation.
3. How long do the results of polynucleotide treatments last?
The results typically last between six and twelve months, and follow-up treatments may be needed to maintain the desired effects.
Citations
[1] Cleveland Clinic Medical Professional. “Cheek Lift.” Cleveland Clinic, 25 Aug. 2025, my.clevelandclinic.org/health/procedures/17232-cheek-lift.
[2] Lee, So Young, et al. “Midface Volumization and Skin Quality Enhancement With a Hyaluronic Acid–polynucleotide Hybrid Filler: A 24-week Prospective Open-label Study.” Journal of Dermatological Treatment, vol. 37, no. 1, Feb. 2026, p. 2621537. https://doi.org/10.1080/09546634.2026.2621537.
[3] NK, Rho, et al. Expert Perspectives: Evidence-Based Applications of Polynucleotides (PNs) in Aesthetic Medicine and Dermatology. 1 Jan. 2026, repository.li.mahidol.ac.th/items/c922ca09-bbf8-4839-8d8b-b307a179ef7b.
[4] Park, Kui Young, et al. “Long-chain Polynucleotide Filler for Skin Rejuvenation: Efficacy and Complications in Five Patients.” Dermatologic Therapy, vol. 29, no. 1, Nov. 2015, pp. 37–40. https://doi.org/10.1111/dth.12299.
This content was prepared and reviewed under our editorial guidelines , which govern how we source, verify, and update clinical and product information. Every claim is checked against peer-reviewed research, manufacturer documentation, or regulatory guidance before publication.
